Axonyx Inc (AXYX)

[bigworld]

Master: Rathoff had not been in place long enough. The previous management was primarily at fauly. Plus, the previous studies measured the effects subjectively and dose Phenserine too low to be beneficial for most of the study participants. By now utilizing PET scan imaging the drug's effects can be demonstrated conclusively. I think the six month evaluations at the institute in Sweden will further demonstrate this. But I understand your reluctance and the poor track record the company demonstrated last year. It is the main thing hindering progress in the stock price. But I have patience. I almost always make money on my biotechs. Not always a fortune, but I tend to buy really low and can then afford to ride the "waves". Thanks for your input.